Wilma D. Heemsbergen

Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy

Stéphanie Peeters, Wilma D. Heemsbergen, P. Koper et al. · Journal of Clinical Oncology · 2006 · 977 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial

Luca Incrocci, Ruud C. Wortel, Wendimagegn Alemayehu et al. · The Lancet Oncology · 2016 · 478 citations

Medicine, Radiation Oncology, Urology +14

Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy

Stéphanie Peeters, Wilma D. Heemsbergen, Wim L.J. van Putten et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 446 citations

Medicine, Radiation Oncology, Urology +12

Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer

Abrahim Al‐Mamgani, Wim L.J. van Putten, Wilma D. Heemsbergen et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 417 citations

Medicine, Radiation Oncology, Urology +14

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial

Shafak Aluwini, Floris J. Pos, Erik C. Schimmel et al. · The Lancet Oncology · 2016 · 313 citations · Full text

Medicine, Oncology, Radiation Oncology +16